510 related articles for article (PubMed ID: 15515826)
21. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.
Bouros D; Schiza S; Tzanakis N; Chalkiadakis G; Drositis J; Siafakas N
Am J Respir Crit Care Med; 1999 Jan; 159(1):37-42. PubMed ID: 9872815
[TBL] [Abstract][Full Text] [Related]
22. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
Uyan AP; Ozyürek H; Yilmaz E
Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
[TBL] [Abstract][Full Text] [Related]
23. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
Sahn SA
Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
[TBL] [Abstract][Full Text] [Related]
24. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.
Tokuda Y; Matsushima D; Stein GH; Miyagi S
Chest; 2006 Mar; 129(3):783-90. PubMed ID: 16537882
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural fibrinolytic therapy for pleural infection.
Bouros D; Tzouvelekis A; Antoniou KM; Heffner JE
Pulm Pharmacol Ther; 2007; 20(6):616-26. PubMed ID: 17049447
[TBL] [Abstract][Full Text] [Related]
26. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions.
Henke CA; Leatherman JW
Am Rev Respir Dis; 1992 Mar; 145(3):680-4. PubMed ID: 1546851
[TBL] [Abstract][Full Text] [Related]
27. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
Cameron R; Davies HR
Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
[TBL] [Abstract][Full Text] [Related]
28. Utility of fibrinolytic agents for draining intrapleural infections.
Bouros D; Schiza S; Siafakas N
Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
[TBL] [Abstract][Full Text] [Related]
29. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
Israel EN; Blackmer AB
Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
[TBL] [Abstract][Full Text] [Related]
30. Efficacy, safety and tolerability of streptokinase in multiloculated empyema.
Khan N; Mian I; Javed A; Wazir S; Yousaf M
J Ayub Med Coll Abbottabad; 2003; 15(4):20-2. PubMed ID: 15067826
[TBL] [Abstract][Full Text] [Related]
31. Management of thoracic empyema in children.
Kiliç N; Celebi S; Gürpinar A; Hacimustafaoglu M; Konca Y; Ildirim I; Dogruyol H
Pediatr Surg Int; 2002 Jan; 18(1):21-3. PubMed ID: 11793057
[TBL] [Abstract][Full Text] [Related]
32. Fibrinolytics in the treatment of parapneumonic effusions.
Bouros D; Schiza S; Siafakas N
Monaldi Arch Chest Dis; 1999 Jun; 54(3):258-63. PubMed ID: 10441983
[TBL] [Abstract][Full Text] [Related]
33. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
[TBL] [Abstract][Full Text] [Related]
34. Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.
Bouros D; Schiza S; Panagou P; Drositis J; Siafakas N
Thorax; 1994 Sep; 49(9):852-5. PubMed ID: 7940420
[TBL] [Abstract][Full Text] [Related]
35. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study.
Misthos P; Sepsas E; Konstantinou M; Athanassiadi K; Skottis I; Lioulias A
Eur J Cardiothorac Surg; 2005 Oct; 28(4):599-603. PubMed ID: 16129614
[TBL] [Abstract][Full Text] [Related]
36. [Intrapleural streptokinase in the treatment of complicated parapneumonic empyema].
Fernández Fernández A; Giachetto Larraz G; Giannini Fernández G; Garat Gómez MC; Vero Acevedo MA; Pastorini Correa J; Castillo Casati C; Pírez García MC; Servente Luquetti L; Ferrari Castilla AM
An Pediatr (Barc); 2007 Jun; 66(6):585-90. PubMed ID: 17583620
[TBL] [Abstract][Full Text] [Related]
37. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
Khemasuwan D; Sorensen J; Griffin DC
Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
[TBL] [Abstract][Full Text] [Related]
39. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial.
Jerjes-Sánchez C; Ramirez-Rivera A; Elizalde JJ; Delgado R; Cicero R; Ibarra-Perez C; Arroliga AC; Padua A; Portales A; Villarreal A; Perez-Romo A
Chest; 1996 Jun; 109(6):1514-9. PubMed ID: 8769503
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural streptokinase for the treatment of childhood empyema.
Ho MY; Chen HY; Yen YH; Yang YS; Lien SH
Acta Paediatr Taiwan; 2007; 48(5):251-6. PubMed ID: 18254573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
